Periop Nursing

Latest Issue of OR Manager
January 2025
Home Periop Nursing

Brigid Gillespie: Advancing OR nursing with evidence-based practice

She is the person who says, “Show me the evidence,” says Brigid Gillespie, PhD, BHlth Sc (Hons), RN, a conjoint professor of Patient Safety in Nursing at the Gold Coast University Hospital and Griffith School of Nursing and Midwifery in Queensland, Australia. Gillespie spoke to OR Manager about the role…

Read More

By: Amy Bethel, MPA, BSN, RN, NE-BC
June 28, 2022
Share

The Munro Scale: Journey from conception to validity and reliability

After a journey of more than 20 years, validity and reliability studies for the Munro Pressure Injury Risk Assessment Scale for Perioperative Patients (Munro Scale) show that the Munro Scale works. The Munro Scale, created by Cassendra A. Munro, PhD, MSN, RN, RNFA, CNOR, is the first standard tool that…

Read More

By: Judith M. Mathias, MA, BS, RN
June 28, 2022
Share

Sessions on recruitment, retention at OR Manager Conference

Nationally known for her work in helping current and future nurse leaders to develop their leadership and coaching skills, Rose O. Sherman, EdD, RN, NEA-BC, FAAN, will return to the OR Manager Conference in Denver, Colorado, in October 2022. Over the past 2 years, Sherman has done 85 virtual workshops…

Read More

By: Tarsilla Moura
June 28, 2022
Share

Engaging student nurses to prime the OR nurse pump: Part 2

Generating student interest in the OR can help OR leaders fill staffing gaps. For example, Debra Sparks, MSM, BSN, RN, CNOR, director of regional perioperative services for The Metro Health System in Cleveland, Ohio, has hired nurses who spent time in the organization as part of their university-based OR coursework…

Read More

By: Cynthia Saver, MS, RN
June 28, 2022
Share

Sponsored Message

Succession planning post-COVID: Identifying the right people

When Donna Doyle, DNP, RN, CNOR, NE-BC, perioperative consultant with DJD Consulting Services in Columbus, Ohio, thinks of succession planning, the British royal family comes to mind. “That is the epitome of succession planning,” she says. “You know exactly who’s in what position, who is next up, and who is…

Read More

By: Jennifer Lubell
June 28, 2022
Share

Newer COVID-19 subvariants show substantial escape from vaccination, previous infection immunity

Editor's Note In a letter published in the New England Journal of Medicine, researchers at Beth Israel Deaconess Medical Center, Boston, report that the three Omicron subvariants (BA.2.12.1, BA.4, and BA.5) currently dominant in the US substantially escape neutralizing antibodies induced by both vaccination and previous COVID-19 infection. The researchers…

Read More

By: Judy Mathias
June 23, 2022
Share

Sponsored Message

The Joint Commission: New R3 Report on reducing healthcare disparities

Editor's Note The Joint Commission on June 22 announced a new “R3 Report—Issue 36: New Requirements to Reduce Health Care Disparities,” which examines the rationale and references behind new and revised requirements to reduce healthcare disparities in accredited organizations, effective January 1, 2023. Among the new and revised requirements: A…

Read More

By: Judy Mathias
June 23, 2022
Share

Factors linked to anxiety, depression during first year of COVID-19

Editor's Note This survey study, led by researchers at Harvard Medical School, Boston, finds that clinically significant anxiety and depression increased only modestly overall in US adults in 2020. In this study of more than 1.4 million respondents in the Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance…

Read More

By: Judy Mathias
June 16, 2022
Share

Study: Best way to test for COVID-19 is nasopharyngeal swab

Editor's Note This study by researchers from Cornell University finds that nasopharyngeal swabs taken from back inside the nostril were more effective at detecting COVID-10 than saliva tests or swabs just inside the nostril or under the tongue. Comparing different samples from 77 patients, the researchers found that: Nasopharyngeal samples…

Read More

By: Judy Mathias
June 15, 2022
Share

FDA: Class I recall of Woodside Acquisitions’ Oral Rapid and Joysbio SARS-CoV-2 Antigen Rapid Test Kits

Editor's Note The Food and Drug Administration (FDA) on June 9 updated the Class I recall by Woodside Acquisitions Inc of its Oral Rapid SARS-CoV-2 Antigen Rapid Test Kits and Joysbio SARS-CoV-2 Antigen Rapid Test Kits (Colloidal Gold) that are not authorized, cleared, or approved by the FDA. The FDA…

Read More

By: Judy Mathias
June 15, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat